|
Forecast
Period
|
2025-2029
|
|
Market
Size (2023)
|
USD
4.15 Billion
|
|
Market
Size (2029)
|
USD
5.50 Billion
|
|
CAGR
(2024-2029)
|
4.75%
|
|
Fastest
Growing Segment
|
Alcohol
|
|
Largest
Market
|
North
America
|
Market Overview
Global Drug Of
Abuse Testing Services Market was valued at USD 4.15 Billion in 2023 and is
anticipated to project impressive growth in the forecast period with a CAGR of 4.75%
through 2029. The global Drug of Abuse (DOA) Testing Services market is
experiencing a robust expansion, primarily fueled by a heightened societal
awareness of substance abuse and a growing demand for drug testing across
critical sectors such as healthcare, corporate environments, and law
enforcement. This increase in demand is particularly evident in the cannabis
testing segment, which is gaining significant traction due to the legal and
regulatory shifts surrounding the legalization of marijuana in multiple regions.
As cannabis use, both medicinal and recreational, becomes more widespread, the
need for reliable and efficient drug testing solutions is accelerating.
On the
technological front, the market is undergoing substantial transformation.
Innovations in testing devices such as portable and point-of-care
technologies are streamlining the testing process, offering faster turnaround
times and enhanced accuracy. Additionally, the incorporation of artificial
intelligence (AI) in drug testing services is setting new standards for results
interpretation, enabling faster, more precise analysis.
The ongoing
expansion of government-driven initiatives aimed at tackling drug dependency
and abuse is providing a solid foundation for market growth. These initiatives
are not only increasing the adoption of drug testing in the criminal justice
system and workplaces but are also pushing educational institutions to
integrate such practices. The convergence of regulatory pressure and
technological advancements positions the market for sustained growth, with
significant shifts expected as stakeholders seek innovative solutions to meet
rising demand.
Key Market Drivers
Rising Substance Abuse and
Drug Dependency
The
rising prevalence of substance abuse and drug dependency is a primary factor
driving the growth of the global Drug of Abuse (DOA) Testing Services market.
This increase in substance abuse, particularly with the growing misuse of
opioids, alcohol, cannabis, and illicit drugs, has spurred demand for more
widespread and effective drug testing services across various sectors. The
global rise in drug dependency and substance use disorders is alarming.
According to the United Nations Office on Drugs and Crime, over 36 million
individuals suffer from drug use disorders, with a growing number of cases
involving opioid use and alcohol dependency. This epidemic has created an
urgent need for comprehensive drug testing solutions to aid in early detection,
monitoring, and treatment. Healthcare providers, addiction treatment centers,
and rehabilitation facilities are increasingly relying on drug testing to
assess patients, determine treatment plans, and track recovery progress. As a
result, testing services are becoming an integral part of the clinical
landscape. Substance abuse is a major concern in the workplace, where drug use
can impair employees’ performance, reduce productivity, and compromise safety
standards. Industries like transportation, construction, and manufacturing are
highly susceptible to the effects of drug use on workforce safety. As drug
testing programs become a standard part of corporate wellness programs,
businesses are investing more in accurate and efficient drug testing services
to ensure a safe working environment. This, in turn, fuels the demand for
testing services across corporate sectors. The increase in substance abuse has
led governments worldwide to implement stricter regulations surrounding drug
use, which directly impacts the demand for drug testing services. Governments
are enforcing drug testing in public institutions, law enforcement agencies,
and schools to tackle the growing crisis of addiction. For example, schools are
increasingly adopting drug testing programs to prevent and manage substance
abuse among students, while law enforcement is relying on testing to monitor
offenders or those suspected of substance use. These regulatory pressures are
driving the market demand for more widespread and accessible drug testing
options.
The
opioid crisis, particularly in North America, has created an unprecedented
demand for drug testing services. The increasing rates of opioid-related deaths
have prompted healthcare systems and law enforcement agencies to enhance their
drug testing capabilities to track misuse patterns and identify individuals at
risk of overdose. Drug testing plays a pivotal role in not only monitoring drug
abuse but also in managing prescriptions and preventing diversion in healthcare
settings, further propelling market growth. With the rising awareness of the
detrimental effects of substance abuse on individuals, families, and
communities, there has been a broader societal push to combat addiction. Public
health campaigns, aimed at educating the public about the risks of substance
abuse, are encouraging individuals to take proactive steps toward detection and
treatment. This growing public awareness of substance abuse is driving the
adoption of drug testing services in healthcare settings, schools, and even
within communities. The growing rates of substance abuse and drug dependency
create a sustained demand for drug testing services across various sectors,
including healthcare, corporate environments, law enforcement, and educational
institutions. This trend not only highlights the increasing importance of drug
testing but also emphasizes the need for reliable, efficient, and accurate
testing solutions to tackle the global substance abuse crisis effectively.
Legalization and Increased Use
of Cannabis
The
legalization of cannabis and its increasing use across both recreational and
medicinal markets are significant drivers of growth for the global Drug of
Abuse (DOA) Testing Services market. The evolving legal landscape, particularly
in North America and Europe, is creating a surge in demand for reliable and
efficient cannabis testing solutions. As cannabis becomes legalized in more
regions, both recreationally and for medical purposes, there is an urgent need
for mechanisms to ensure compliance with legal limits on cannabis use.
Governments are establishing strict regulatory frameworks to monitor
consumption, and businesses are expected to enforce drug testing policies to
comply with these laws. Employers, for instance, need accurate testing methods
to distinguish between legal cannabis use and impairment at the workplace. Law enforcement agencies are also implementing regular cannabis
testing to ensure drivers and workers are within legal limits, pushing for the
adoption of advanced drug testing services. In regions where cannabis is legal,
employers are increasingly incorporating cannabis testing as part of their
routine workplace drug testing programs. This is especially crucial in
safety-sensitive industries such as construction, transportation, and aviation,
where cannabis use may impair an employee’s ability to perform critical tasks.
Businesses are looking for reliable and accurate testing solutions that can
differentiate between recent use (impairment) and past consumption. This trend
is creating a growing demand for testing devices that can analyze blood,
saliva, urine, or breath samples with high precision.
As
cannabis becomes more widely accepted for medicinal purposes, its use in
healthcare settings has also expanded. Medical professionals and healthcare
providers are increasingly using drug tests to monitor patients who are
prescribed cannabis for chronic pain, mental health conditions, and other
ailments. Drug testing in this sector not only ensures adherence to prescribed
dosages but also helps in identifying potential abuse or misuse. Cannabis
testing services are thus being integrated into routine medical assessments and
addiction recovery programs, further boosting market growth. With increasing
cannabis legalization, both recreational and medicinal use have risen
substantially, particularly in North America, where cannabis has been legalized
in several states. As cannabis consumption increases, so does the need for
testing services to monitor usage. This includes both general public use and in
specialized settings like medical dispensaries. As consumer use continues to
rise, so does the demand for testing services that can provide accurate results
in real-time to assess whether individuals are under the influence, driving
further expansion of the testing market. The expanding cannabis market is also
pushing innovation in testing technologies. Advances in cannabis testing
devices, including rapid point-of-care tests and non-invasive methods, are
enabling quicker, more accurate results. For example, breathalyzers specifically
designed for cannabis impairment detection are becoming more prevalent, making
it easier for employers and law enforcement to test individuals on-site. These
innovations in technology are critical in expanding the market, as they address
the rising demand for efficient, cost-effective, and accessible testing
options.
As
cannabis use increases, so do concerns about its effects on public health,
particularly regarding impaired driving and safety risks. Governments and
public health organizations are focusing on educating the public about
responsible use, but the need for robust testing solutions remains critical.
Cannabis testing services provide a critical tool for ensuring that individuals
are not impaired in environments where safety is paramount, such as on the road
or in the workplace. Cannabis testing
services are directly linked to the evolving cannabis legal landscape. The
passage of laws legalizing cannabis in several states and countries is driving
demand for comprehensive testing solutions that can cater to both public health
safety and regulatory compliance. This is particularly important in regions
like North America, where the market for cannabis testing has expanded
significantly with the opening of legalized markets. Additionally, with the
introduction of new legal frameworks, there is a continuous demand for tests
that can keep up with these regulatory changes. The legalization of cannabis
and the corresponding increase in its use for recreational and medicinal
purposes are key drivers of growth for the global Drug of Abuse Testing
Services market. The need for accurate, timely, and regulatory-compliant
cannabis testing solutions is rising across multiple sectors, from workplaces
to healthcare and law enforcement, thereby fostering continued market
expansion. As these trends evolve, the demand for sophisticated, efficient, and
portable cannabis testing solutions is expected to continue to grow.
Technological Advancements in
Testing Devices
Technological
advancements in drug testing devices are a significant driver of growth in the
global Drug of Abuse (DOA) Testing Services market. These innovations are
reshaping the way drug testing is conducted, making it more efficient,
cost-effective, and accessible across various sectors such as healthcare, law
enforcement, and the workplace. One of the most important technological
advancements in drug testing is the development of point-of-care (POC) and
portable testing devices. These devices allow for immediate, on-site drug
testing, which is crucial in environments like workplaces, schools, and law
enforcement. POC devices offer the advantage of providing results in minutes,
eliminating the need for samples to be sent to laboratories for analysis,
thereby reducing wait times and operational costs. This convenience has led to
greater adoption, particularly in industries where timely testing is essential
for safety, such as transportation, manufacturing, and construction. Portable drug testing devices are increasingly being used in roadside checks by
law enforcement, especially for cannabis and alcohol impairment detection.
Devices like breathalyzers and saliva-based testing kits are gaining traction,
as they are easy to use and provide reliable results. This trend is expanding
the market by meeting the needs of both regulatory agencies and businesses
concerned with maintaining safety standards.
The
integration of Artificial Intelligence (AI) and machine learning into drug
testing devices is another game-changing development. AI algorithms are being
employed to analyze test results more accurately and efficiently. By analyzing
patterns in data, AI can enhance the interpretation of test results, helping to
eliminate human error and improve the reliability of drug testing services.
These advancements also reduce the time required for analysis, which is
particularly beneficial in high-stakes environments like law enforcement or
healthcare settings. AI-driven platforms can provide automated
reports and predictions based on historical data, streamlining the
decision-making process for healthcare providers, employers, and law
enforcement officials. This technological integration also supports the growing
need for large-scale drug testing, particularly in workplaces where high
throughput is required. The shift toward non-invasive drug testing methods is
another key technological advancement that is driving the growth of the market.
Traditional urine or blood tests, while effective, are often invasive and
uncomfortable for the subject. Non-invasive testing methods, such as breath
analyzers, saliva tests, and sweat patches, are being developed and refined to
offer accurate results without the need for invasive sample collection. These
technologies are expected to increase the adoption of drug testing, particularly
in sectors where employee or public compliance is essential. For example,
breath analyzers designed to detect cannabis impairment are gaining popularity
due to their non-invasive nature and quick result turnaround times. As
technology improves, these devices are becoming more accurate and capable of
detecting lower concentrations of substances, making them more reliable for
real-time impairment detection. Advances in automation are significantly
enhancing the efficiency of drug testing processes. Automated systems can now
handle sample preparation, analysis, and reporting, reducing the need for
manual intervention and speeding up the overall testing workflow. This is
particularly beneficial in high-demand environments like hospitals, clinics,
and drug testing centers, where large volumes of samples need to be processed
quickly. Automation in drug testing also minimizes the risk of human error and
ensures consistent, high-quality results. The reduction in labor costs and the
improved efficiency of automated systems make drug testing services more
affordable and scalable, driving broader adoption across various sectors.
The
continuous improvement of testing devices has expanded the range of substances
that can be detected. For example, new devices are capable of testing for a
wider variety of drugs, including designer drugs, synthetic cannabinoids, and
opioids. This capability is crucial as the global drug landscape evolves and
the types of substances being abused change. Manufacturers are constantly
upgrading their devices to stay ahead of emerging drug trends, which is
essential for maintaining relevance in a fast-changing market. Advancements in testing sensitivity mean that even small traces of drugs can be
detected in a variety of sample types. This enhanced sensitivity is crucial for
providing accurate results, especially in cases where an individual’s drug use
may not be immediately apparent. As testing capabilities continue to improve,
they will address the need for more comprehensive drug monitoring, especially
in healthcare and law enforcement. Finally, technological advancements are
driving down the cost of drug testing. The development of more efficient and
automated devices reduces the need for expensive reagents and labor-intensive
procedures. As costs decrease, drug testing services become more accessible to
a wider range of industries, including small and medium-sized enterprises
(SMEs), which are increasingly adopting drug testing policies. The scalability
of new technologies also enables businesses and institutions to implement
widespread testing programs without incurring prohibitive costs. Technological
advancements in drug testing devices are fueling the growth of the Drug of
Abuse Testing Services market by enhancing the accuracy, speed, and convenience
of testing. Innovations like portable, non-invasive testing methods, AI-driven
analysis, and automation are making drug testing more efficient,
cost-effective, and scalable across industries. These advancements are not only
improving the quality of testing but also expanding the range of applications
for drug testing, from workplace safety to public health initiatives, further
driving market growth. As technology continues to evolve, the market will see
even more sophisticated and accessible testing solutions emerge, meeting the
increasing demand for reliable drug testing services.
Download Free Sample Report
Key Market Challenges
Regulatory and Legal Hurdles
The
regulatory landscape surrounding drug testing services is one of the most
significant challenges facing the market. Drug testing protocols vary greatly
across regions, with different countries and even individual states having
their own sets of laws and regulations governing the use, collection, and
interpretation of drug test results. For example, the legalization of cannabis
in various regions has introduced complexities in defining legal limits for
impairment, particularly in workplaces and law enforcement settings.
In
addition, regulatory agencies, such as the U.S. Food and Drug Administration
(FDA) or the European Medicines Agency (EMA), often have stringent guidelines
for the approval of drug testing devices, which can slow down the introduction
of innovative testing technologies. These regulatory challenges create barriers
for companies in terms of time-to-market for new testing solutions and may
require substantial investments in compliance, increasing operational costs for
testing service providers. The lack of standardization in testing procedures,
especially in newly legalized markets, complicates the establishment of
universally accepted testing benchmarks, hindering the scalability of drug
testing services.
High Costs of Advanced Testing
Solutions
The
adoption of cutting-edge drug testing technologies, such as AI-driven testing
systems, portable devices, and non-invasive testing methods, often comes with
significant costs. The development, maintenance, and certification of advanced
drug testing devices require substantial investment, making these solutions
expensive for both service providers and end users. For instance, AI-enhanced
testing devices or portable point-of-care solutions often come with a premium
price tag due to the advanced technology involved.
This
high cost of testing solutions presents a barrier to adoption, particularly in
low- and middle-income markets or for smaller businesses and educational
institutions that may find it difficult to justify the investment. Although
these technologies can reduce operational costs in the long run, the initial
expense remains a key obstacle, limiting widespread deployment of drug testing
services across various sectors, including corporate environments and public
health systems.
Privacy and Ethical Concerns
Privacy
and ethical issues surrounding drug testing are another major challenge. Drug
testing often involves the collection of sensitive personal data, such as
biological samples (e.g., urine, saliva, blood) and information about
individuals’ substance use. This raises significant concerns regarding the
confidentiality of test results and the potential misuse of such information.
In workplaces, the collection and storage of personal drug use data can be seen
as an infringement on employee privacy, particularly when testing is mandatory
or random.
There is the risk of discrimination or stigmatization based on drug test
results, particularly in the context of employment or insurance applications.
For example, individuals may be unfairly penalized or fired based on a positive
drug test result, even if it was related to legal drug use such as cannabis.
These privacy and ethical concerns can lead to resistance to drug testing,
particularly in regions with strong privacy laws (e.g., the European Union’s
General Data Protection Regulation, or GDPR), which further complicates market
growth.
Key Market Trends
Integration of Artificial
Intelligence (AI) and Data Analytics in Drug Testing
Artificial
Intelligence (AI) and data analytics are playing an increasingly critical role
in drug testing, enhancing accuracy, efficiency, and decision-making. AI-driven
technologies enable faster analysis of test results, improving the precision of
interpretations and reducing the likelihood of human error. Machine learning
algorithms can analyze large datasets to identify patterns, helping service
providers predict trends in drug abuse, assess risk factors, and streamline
testing protocols.
The
future of drug testing will likely see AI systems integrated directly into
testing devices, allowing for automated result interpretation and real-time
reporting. This integration will improve testing processes for industries that
require rapid and reliable results, such as law enforcement and workplace
safety. The ability to track and analyze data over time will also help improve
compliance, risk management, and overall monitoring efforts, particularly in
workplace and healthcare settings. AI's potential for predictive analytics is
expected to foster more proactive approaches to substance abuse detection and
management, opening new opportunities in the drug testing market.
Growth in On-Site and Remote
Drug Testing Solutions
Another
trend driving the future growth of the drug testing services market is the
expansion of on-site and remote drug testing solutions. As the demand for
convenient, quick, and cost-effective testing rises, technologies enabling
remote and point-of-care (POC) testing are becoming increasingly popular.
On-site testing, such as saliva-based, breathalyzer, and urine drug tests,
allows for immediate results without requiring samples to be sent to a
laboratory.
Remote
drug testing is gaining traction, particularly with the increased adoption of
telemedicine and digital health platforms. These solutions allow individuals to
conduct drug tests at home or in non-traditional settings, with results being
analyzed remotely by healthcare professionals or testing services. This trend
is expected to grow in response to the rising demand for personal health
monitoring and the need for flexibility in drug testing across industries such
as healthcare, education, and the workplace.
Focus on Expanding Test Panel
and Detection Capabilities
As
the global drug abuse landscape evolves, there is a clear trend toward
expanding the range of substances tested and enhancing detection capabilities.
The rise of synthetic drugs, novel psychoactive substances (NPS), and new
formulations of illicit substances means that drug testing services must adapt
to detect a broader spectrum of substances. The future will likely see
continuous improvements in drug testing technologies to accommodate a growing
variety of illicit and legally available drugs, such as synthetic cannabinoids,
opioids, and other designer drugs.
Additionally,
advances in testing sensitivity are enabling the detection of drugs at lower
concentrations, improving the accuracy of tests, particularly in cases of
impairment detection, which is critical for workplaces and law enforcement.
Testing devices with expanded panels, capable of identifying a range of
substances from alcohol and opioids to cannabis and NPS, are expected to become
standard across sectors like healthcare, public safety, and corporate
environments. This trend toward more comprehensive testing capabilities will
drive the need for advanced, multi-target testing systems, enhancing the
overall market potential.
Segmental Insights
Drug Class Insights
Based
on the category of Drug Class, the Cannabis/marijuana segment emerged as the
dominant in the global market for Drug Of Abuse Testing Services in 2023. The
legal landscape for cannabis is evolving rapidly, with many countries and
regions around the world moving towards legalization, either for recreational
or medicinal use. In North America, for instance, cannabis has been legalized
in multiple states in the U.S., and Canada legalized cannabis at the national
level in 2018. In Europe, certain countries, such as Germany and the
Netherlands, have been gradually expanding cannabis use for medical purposes. This
regulatory shift has driven a significant rise in cannabis consumption, both
recreationally and medicinally. As a result, there is a greater need for
reliable and accurate cannabis testing solutions to ensure compliance with
legal limits, monitor impairment levels in the workplace, and enforce road
safety laws. Drug testing services in this segment are crucial for assessing
whether individuals are using cannabis within legal boundaries, driving the
demand for cannabis-specific testing tools across various sectors, including
law enforcement, healthcare, and employment.
Cannabis
has gained substantial traction as a treatment for various medical conditions,
including chronic pain, mental health issues (like anxiety and depression), and
neurological disorders such as epilepsy. The growing number of patients being
prescribed medical cannabis has fueled demand for cannabis testing in
healthcare settings. For medical professionals, it is essential to monitor the
usage of cannabis among patients, ensuring adherence to prescribed doses and
preventing misuse or abuse. Drug testing services are integral in this process,
as they help confirm that patients are using cannabis appropriately, preventing
overuse or adverse reactions. This rise in medicinal cannabis use is
significantly contributing to the dominance of the cannabis segment in the
global drug testing market. The legalization of cannabis in many jurisdictions
has led to increasing concerns about workplace safety, especially in industries
where employees operate heavy machinery or perform safety-sensitive tasks.
Employers are now faced with the challenge of enforcing drug-free workplace
policies while managing the legal complexities surrounding cannabis use. Cannabis
testing in the workplace has become essential to ensure that employees are not
impaired by cannabis while on the job, particularly in sectors like
transportation, construction, and manufacturing. Additionally, drug testing for
cannabis is critical in law enforcement and regulatory agencies, which often
test individuals for impairment in the context of road safety. The demand for
accurate, reliable, and non-invasive cannabis testing methods, such as saliva
tests, breathalyzers, and urine samples, has surged in response to these safety
concerns. This has directly driven the growth of cannabis testing services
within the broader drug testing market. These factors collectively contribute
to the growth of this segment.
Download Free Sample Report
Regional Insights
North
America emerged as the dominant in the global Drug Of Abuse Testing Services
market in 2023, holding the largest market share in terms of value. North
America, particularly the United States, faces a significant substance abuse
crisis, with high rates of opioid misuse, rising marijuana consumption, and
increasing cases of synthetic drug abuse. According to the National Institute
on Drug Abuse (NIDA), millions of Americans are affected by substance use
disorders annually, creating a substantial demand for drug testing services. The
opioid epidemic in the U.S. is a major driver of the DOA testing market. With
fentanyl and other synthetic opioids contributing to a surge in overdose cases,
government and private organizations are investing heavily in drug testing
programs to monitor and combat substance misuse. This public health challenge
has led to widespread adoption of drug testing services across sectors,
including healthcare, criminal justice, and workplaces, further reinforcing
North America’s dominance in the market.
The
legalization of cannabis for recreational and medicinal purposes across
numerous U.S. states and Canada has reshaped the drug testing landscape. While
legalization has driven acceptance of cannabis use, it has also necessitated
stringent monitoring for impairment in workplaces and public safety settings,
such as road safety enforcement. Employers and law enforcement agencies have
increased their reliance on cannabis-specific drug testing services to ensure
compliance with regulations, maintain workplace safety, and prevent accidents.
This heightened focus on cannabis testing has significantly boosted the market
in North America, positioning the region as a leader in cannabis testing
solutions. North America has some of the most rigorous workplace drug testing
regulations in the world, particularly in industries such as transportation,
construction, and healthcare. In the U.S., regulatory bodies like the
Department of Transportation (DOT) mandate drug testing for safety-sensitive
roles, ensuring a consistent demand for testing services. Workplace testing
policies extend beyond pre-employment screening to include random,
post-incident, and reasonable suspicion testing. These comprehensive testing
frameworks are a key factor in North America’s dominance in the DOA testing
market, as employers across the region invest in drug testing services to
comply with legal requirements and maintain productivity.
Recent Developments
- In
June 2024- Quest Diagnostics, a prominent provider of diagnostic information
services, and Allina Health, a leading non-profit healthcare system, have
announced a definitive agreement under which Quest will acquire specific
laboratory assets from Allina Health. This strategic acquisition aims to
enhance the accessibility and affordability of advanced laboratory services for
communities across Minnesota and western Wisconsin.
- In
August 2024, Quest Diagnostics, a leading provider of diagnostic information
services, and University Hospitals, a top nonprofit health system and academic
medical center, have announced a definitive agreement for Quest to acquire
select assets from University Hospitals' outreach laboratory services business.
This partnership aims to expand Quest's capabilities while enhancing access to
diagnostic services for patients in the communities served by University
Hospitals.
- In
May 2024, Omega Laboratories, a leading provider of drug testing services, has
announced a strategic partnership with Cannabix Technologies Inc., a
trailblazer in cannabis breathalyzer technology. Under this collaboration,
Omega will serve as the exclusive provider of laboratory services, combining
their expertise to advance innovative solutions for drug testing and safety
assurance. This partnership represents a significant step forward in developing
cutting-edge technologies to address evolving industry needs.
Key Market Players
- Quest
Diagnostics Incorporated
- Abbott
- Clinical
Reference Laboratory, Inc
- Laboratory
Corporation of America Holdings
- Cordant
Health Solutions
- Legacy
Medical Services LLC
- DrugScan
- Omega
Laboratories, Inc
- Psychemedics
Corporation
- Millennium
Health
|
By
Drug Class
|
By
Region
|
- Alcohol
- Cannabis/Marijuana
- Cocaine
- Opioids
- Amphetamine
& Methamphetamine
- LSD
- Others
|
- North
America
- Europe
- Asia
Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the Global Drug Of Abuse Testing
Services Market has been segmented into the following categories, in addition
to the industry trends which have also been detailed below:
- Drug Of Abuse Testing Services Market, By Drug Class:
o Alcohol
o Cannabis/Marijuana
o Cocaine
o Opioids
o Amphetamine & Methamphetamine
o LSD
o Others
- Drug Of Abuse Testing Services Market, By
Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Drug
Of Abuse Testing Services Market.
Available Customizations:
Global Drug Of Abuse Testing Services market report
with the given market data, TechSci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Drug Of Abuse
Testing Services Market is an upcoming report to be released soon. If you wish
an early delivery of this report or want to confirm the date of release, please
contact us at [email protected]